|
|
???tair.name??? >
???browser.page.title.author???
|
"punwaney r"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
|
Sheikh, SZ; Scheinberg, MA; Wei, JCC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MRA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Ros, JO; Levy, RA; Bass, DL; Terres, JR; Punwaney, R; Harris, J; Nami, A; Pierce, A; Thorneloe, KS; Ji, B; Roth, DA |
| 中山醫學大學 |
2021 |
SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
|
Sheikh, S; Scheinberg, M; Wei, JCC; Tegzova, D; Stohl, W; Mucenic, T; Punwaney, R; Kurrasch, R; Harris, J; Muzaffar, S; Fernandes, S; Fox, NL; Liu, A; Quasny, H; Roth, D |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
